MedPath

Comparing adding diltiazem to tolterodine to treat overactive bladder after prostatectomy

Not Applicable
Conditions
Overactive bladder syndrome.
other specified disorders of bladder
Registration Number
IRCT2014112214333N25
Lead Sponsor
Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
80
Inclusion Criteria

Inclusion: male patients ranging from 55 to 80, patients with prostatectomy; patients in urology department, patients with blood pressure background.
Exclusion: patients with heart failure, bradycardia, having background of radiation to bladder, BCG therapy, systolic pressure less than 120 mm Hg, dependency of patient to medicine.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: A day before and four weeks after surgery. Method of measurement: With a pressure set.;Urinary system. Timepoint: A day before and four weeks after surgery. Method of measurement: Based on IPSS.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath